Nabriva’s XENLETA Demonstrates High Efficacy in Patients of Advanced Age with Community-Acquired Bacterial Pneumonia (CABP) by Seini Moimoi | Oct 13, 2020 | Portfolio News
Talaris Therapeutics Closes $115 Million Series B Financing by Seini Moimoi | Oct 6, 2020 | Portfolio News
Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II by Seini Moimoi | Oct 5, 2020 | Portfolio News
Dascena Receives FDA EUA for COVID-19 Hemodynamic Instability and Respiratory Decompensation Prediction System by Seini Moimoi | Oct 2, 2020 | Portfolio News
HLS Therapeutics Acquires Portfolio of Four Royalty Interests by Seini Moimoi | Sep 30, 2020 | Portfolio News
